← Back to Search

Other

PBI-100 Topical Cream for Psoriasis

Phase 1
Waitlist Available
Research Sponsored by Pyramid Biosciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from dosing until discharge, up to day 28
Awards & highlights

Study Summary

This trial is testing a new cream to see if it is effective and safe for people with psoriasis.

Eligible Conditions
  • Psoriasis
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from dosing until discharge, up to day 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and from dosing until discharge, up to day 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Adverse Events (AEs) in Adult Subjects with Psoriasis
Number of Adverse Events (AEs) in Healthy Adult Subjects

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PBI-100 Topical CreamExperimental Treatment1 Intervention
SAD: 4 cohorts of subjects are planned to receive a single dose of PBI-100 topical cream in one of three dosage strengths, administered once or twice daily MAD: 3 cohorts of subjects are planned to receive one of three dosage strengths of PBI-100 administered once or twice daily for periods of 14 consecutive days
Group II: VehiclePlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PBI-100 Topical Cream
2021
Completed Phase 1
~70

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Pyramid BiosciencesLead Sponsor
6 Previous Clinical Trials
135 Total Patients Enrolled
Chief Medical OfficerStudy DirectorPyramid Biosciences
122 Previous Clinical Trials
21,492 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Michigan
Oklahoma
How old are they?
18 - 65
< 18
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
TKL Research Inc.
Recent research and studies
clinicaltrials.govStudy
A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream
2021. "A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05514353.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top